| 中文名 | 氟罗沙星 |
| 英文名 | Fleroxacin |
| 别名 | 氟罗沙星 氟罗沙星(标准品) 氟罗沙星溶液, 1000PPM 8-二氟-1-(2-氟乙基)-1 4-二氢-7-(4-甲基-1-哌嗪基)-4-氧-3-喹啉羧酸 6,8-二氟-1-(2-氟乙基)-1,4-二氢-7-(4-甲基-1-哌嗪基)-4-氧-3-喹啉羧酸 氟罗沙星,多氟哌酸,多氟沙星, 6,8-二氟-1-(2-氟乙基)1,4-二氢-7-(4-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸 6,8-二氟-1-(2-氟乙基)1,4-二氢-7-(4-甲基哌嗪)-4-氧代-3-喹啉羧酸 AM-833 RO 23-6240 多氟哌酸 多氟沙星 |
| 英文别名 | Fleroxacin Erlotinib-d12 HCl 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-3-ic acid 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoxylic acid 6,8-difluoro-1-(2-fluoroethyl)-4-keto-7-(4-methylpiperazin-1-yl)xylic acid 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-xylic acid 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-ic acid 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroxylic acid 6,8-Difluoro-1-(2-Fluoroethyl)-1,4-Dihydro-7-(4-Methyl-1-Piperazinyl)-4-Oxo-3-ic Acid 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl)xylic acid AM-833, Ro-23-6240, Megalocin, Megalone, , 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-ic Acid AM-833, Megalocin, Megalone, 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-ic acid, 6,8-Difluoro-1-(2-fluoroethyl)1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-ic acid |
| CAS | |
| EINECS | |
| 化学式 | C17H18F3N3O3 |
| 分子量 | 369.34 |
| InChI | InChI=1/C17H18F3N3O3/c(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26) |
| 密度 | 1.409±0.06 g/cm3(Predicted) |
| 熔点 | 264-266°C |
| 沸点 | 535.3±50.0 °C(Predicted) |
| 闪点 | 277.6°C |
| 蒸汽压 | 2.73E-12mmHg at 25°C |
| 溶解度 | 0.1 M NaOH: soluble10mg/mL |
| 折射率 | 1.568 |
| 酸度系数 | -0.54±0.20(Predicted) |
| 存储条件 | Sealed in dry,Room Temperature |
| 外观 | solid |
| 颜色 | white to off-white |
| Merck | 14,4099 |
| 物化性质 | 急性毒性LD50小鼠，大鼠，犬(mg/kg)：＞4000，＞4000，＞1000口服。急性毒性LD50小鼠(mg/kg)：217～237静脉注射。盐酸氟罗沙星(Fleroxacin Hydrochloride)：Cl7H18F3N3O3?HCl。在水中结晶，熔点269～271℃(分解)。 |
| 产品用途 | 属广谱抗菌药 |